Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NADK | O95544 | 2/20 | 0.79 |
| ▸ | HSPA8 | P11142 | 3/20 | 0.78 |
| ▸ | HSPA5 | P11021 | 2/20 | 0.78 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.71 |
| ▸ | GAPDH | P04406 | 3/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.67 |
| ▸ | HBB | P68871 | 1/20 | 0.67 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.63 |
| ▸ | SLC28A2 | O43868 | 2/20 | 0.62 |
| ▸ | DPP4 | P27487 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.62 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.62 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.62 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12030991 | 1.00 | NADK (0.79) | NADKHSPA8HSPA5RXFP1GAPDH | |
| SCHEMBL20419274 | 1.00 | NADK (0.79) | NADKHSPA8HSPA5RXFP1GAPDH | |
| SCHEMBL6671819 | 1.00 | NADK (0.79) | NADKHSPA8HSPA5RXFP1GAPDH | |
| SCHEMBL14435669 | 1.00 | NADK (0.79) | NADKHSPA8HSPA5RXFP1GAPDH | |
| SCHEMBL13587343 | 1.00 | NADK (0.79) | NADKHSPA8HSPA5RXFP1GAPDH | |
| SCHEMBL440925 | 1.00 | NADK (0.79) | NADKHSPA8HSPA5RXFP1GAPDH | |
| SCHEMBL1106674 | 1.00 | NADK (0.79) | NADKHSPA8HSPA5RXFP1GAPDH | |
| SCHEMBL29707221 | 0.99 | NADK (0.78) | NADKHSPA8HSPA5RXFP1GAPDH | |
| SCHEMBL28823544 | 0.99 | NADK (0.78) | NADKHSPA8HSPA5RXFP1GAPDH | |
| Phosphoric Acid SCHEMBL8628967 | 0.94 | NADK (0.72) | NADKHSPA8HSPA5RXFP1GAPDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1452 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304916-A1 | METHODS AND COMPOSITIONS FOR GENERATING VASCULAR LEPTOMENINGEAL CELLS | TRAILHEAD BIOSYSTEMS INC (US) | 2025-10-02 | — | — | US | claimed |
| CN-117402814-A | Endothelial induction culture medium and method for inducing differentiation of pluripotent stem cells into vascular endothelial cells | 北京朴汇细胞生物科技有限公司 | 2024-01-16 | — | — | CN | claimed |
| US-20230332103-A1 | Methods and Compositions for Generating Human Forebrain Neural Progenitor Cells and for Maturation Thereof to Parvalbumin+ Interneurons | TRAILHEAD BIOSYSTEMS INC. | 2023-10-19 | — | — | US | claimed |
| WO-2023075913-A1 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN FOREBRAIN NEURAL PROGENITOR CELLS AND FOR MATURATION THEREOF TO PARVALBUMIN+ INTERNEURONS | TRAILHEAD BIOSYSTEMS INC. (US) | 2023-05-04 | — | — | WO | claimed |
| US-20220349874-A1 | METHODS OF GENERATING HUMAN ENDOMETRIAL STROMAL FIBROBLASTS AND THREE-DIMENSIONAL MULTI-LAYERED HUMAN ENDOMETRIAL TISSUE COMPOSITIONS | NORTHWESTERN UNIVERSITY | 2022-11-03 | — | — | US | claimed |
| US-20220002737-A1 | ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN EXPRESSION | CUREVAC AG (DE) | 2022-01-06 | — | — | US | claimed |
| CN-112079883-A | Production process of vidarabine | 兰州欣立医药科技有限责任公司 | 2020-12-15 | — | — | CN | claimed |
| EP-2877855-B1 | MULTISIGNAL REAGENTS FOR LABELING ANALYTES | ENZO LIFE SCIENCES INC (US) | 2020-04-15 | — | — | EP | claimed |
| WO-2020028134-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2020-02-06 | — | — | WO | claimed |
| US-20190285621-A1 | MULTISIGNAL REAGENTS FOR LABELING ANALYTES | ENZO LIFE SCIENCE, INC. (US) | 2019-09-19 | — | — | US | claimed |
| US-20040110718-A1 | Anti-HCV nucleoside derivatives | DEVOS RENE (GB) | 2004-06-10 | — | — | US | claimed |
| WO-2004035083-A2 | COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS | MEDICAL RESEARCH COUNCIL (GB) | 2004-04-29 | — | — | WO | claimed |
| WO-2003104482-A1 | SIGNALS AND MOLECULAR SPECIES INVOLVED IN SENESCENCE | METABOLIC ENGINEERING LABORATORIES CO., LTD. (KR) | 2003-12-18 | — | — | WO | claimed |
| US-6512004-B2 | Activation of kinase | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-01-28 | — | — | US | claimed |
| US-20030008841-A1 | Anti-HCV nucleoside derivatives | F. HOFFMAN-LA ROCHE, A SWISS COMPANY (CH) | 2003-01-09 | — | — | US | claimed |
| US-20020142990-A1 | Promoters of neural regeneration | NIH-DEITR | 2002-10-03 | — | — | US | claimed |
| WO-2002057425-A2 | NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RNA-DEPENDENT RNA VIRAL POLYMERASE | MERCK & CO., INC. (US) | 2002-07-25 | — | — | WO | claimed |
| US-20020006916-A1 | Activation of kinase | NIH-DEITR | 2002-01-17 | — | — | US | claimed |
| US-6284539-B1 | IDENTIFYING CELLS EXPRESSING TYROSINE HYDROXYLASE; INCUBATING STEM CELLS WITH POLYNUCLEOTIDE ENCODING TRANSCRIPTION REGULATOR; PARKINSON'S DISEASE; DOPAMINERGIC CELL FATE | NEURALSTEM BIOPHARMACEUTICALS, LTD. | 2001-09-04 | — | — | US | claimed |
| EP-0066918-A1 | Anti-inflammatory compositions exhibiting minimized gastric damage | THE PROCTER & GAMBLE COMPANY (US) | 1982-12-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030008841-A1 | Anti-HCV nucleoside derivatives | PNP, HAVCR2, NUDT14 | NADK 134/4885HSPA8 1847/4885HSPA5 1928/4885 |
| US-20040110718-A1 | Anti-HCV nucleoside derivatives | PNP, HAVCR2, NUDT14 | NADK 134/4885HSPA8 1847/4885HSPA5 1928/4885 |
| US-20220002737-A1 | ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN EXPRESSION | CPSF6, CPSF1, RNMT | NADK 1380/4885HSPA8 1329/4885HSPA5 681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.